Effect of empagliflozin on epicardial adipose tissue volume in patients with type 2 diabetes, or prediabetes, and heart failure with reduced ejection fraction (SUGAR-DM-HF)
Event:
ESC Congress 2024
Topic:
Imaging
Session:
Obesity and heart failure: what's new?
